Evidence map›Paper›PMID 37626756›Full record

ArticleBiomedicines2023

Functional Recovery after the Application of Amniotic Tissues and Methylene Blue during Radical Prostatectomy-A Pilot Study.

Dimitri Barski, Igor Tsaur, Mihaly Boros, Jan Brune, Thomas Otto

Abstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dimitri BarskiDepartment of Urology, Rheinland Klinikum Neuss, 41464 Neuss, Germany.
Igor TsaurDepartment for Urology and Pediatric Urology, University Medical Center of Johannes Gutenberg, 55131 Mainz, Germany.ORCID 0000-0001-5107-3523
Mihaly BorosInstitute of Surgical Research, University of Szeged, 6720 Szeged, Hungary.
Jan BruneDIZG-Deutsches Institut für Zell-und Gewebeersatz gGmbH, 12555 Berlin, Germany.ORCID 0000-0002-4395-6411
Thomas OttoDepartment of Urology, Rheinland Klinikum Neuss, 41464 Neuss, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amniotic tissues and methylene blue (MB) provide the ability for neuroregeneration, and MB enables intraoperative neurostaining. We first combined the techniques to explore a neuroprotective effect on early functional outcomes in a retrospective proof-of-concept trial of 14 patients undergoing radical prostatectomy (RP). The patients were followed up at a median of 13 months, and the continence and potency rates were reported. Early recovery of continence was found after three months. No effect on potency was detected. The findings indicate the feasibility of this tissue-engineering strategy, and justify prospective comparative studies.

Indexed as

amnionimpotenceincontinenceMBprostatectomytissue engineering

Identifiers

PMID37626756
PMCPMC10452294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.